AKT1 and Alzheimer disease: In addition, chronic administration of AM404 at low dose (0.25 mg/kg; i.p.)improved spatial cognition and attenuated pathological features, which might be in part by the Akt/GSK3β pathway in hyperglycemic 3×Tg-AD mice.